中文产业新闻精选评分75Chinese source
三生国健抗IL-1β单抗SSGJ-613获NMPA批准上市，用于痛风性关节炎急性发作
三生制药，又一款痛风新药获批！
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
三生制药，又一款痛风新药获批！
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.